BeiGene is developing a pipeline of oral small molecules and monoclonal antibodies to fight cancer. Get up to date with the BeiGene hematology pipeline and clinical trials.
The Satellite Symposium at the 3rd How to Diagnose and Treat Lymphoma Conference of the European School of Hematology was chaired by Catherine Thieblemont joined by Anna Maria Frustaci, and Antonio Salar Silvestre as they discussed BTK and BCL2 inhibition as emerging approaches for lymphoma therapy.
The Satellite Symposium at ISHL12 was chaired by Peter Borchman joined by Paul Bröcklemann, Graham Collins and Pier L. Zinzani as they discussed the opening paths to the next chapters of lymphoma treatment.
The Satellite Symposium at EHA2022 was chaired by Paolo Ghia joined by Federico Pea, Barbara Eichhorst, Shirley D’Sa and Ramón García Sanz. They discussed next-generation BTK inhibitors in the treatment of B-cell malignancies.
The Satellite Symposium at BSH 2022 provided expert insights into treatment options in WM, the emerging role of BTKis in WM, and BTKi-associated toxicities and their management.